Educational insights about GARD

When you watch our webinars, you will learn in what ways GARD can support your testing needs. We cover essential topics that range from genomics and machine learning and why GARD has such robust prediction for in vitro sensitization testing, to difficult-to-test samples and quantitative potency assessment.

© SenzaGen

Interested in more information?

Contact us to discuss how the GARD assays can support your testing needs.

May 25, 2022
Medical Devices’ principal mode of action by physical means: case studies on 3D reconstructed human tissues
By Dr Laura Ceriotti@VitroScreen, Dr Paolo Buratti@VitroScreen

April 28, 2022
SenzaGen’s 2022 SOT Scientific Session: New GARD® data on agrochemical formulations, fragrance materials, medical devices and metals
By Dr Andy Forreryd@SenzaGen, Dr Christopher Choi@Takasago, Dr Karla Lienau@Sonova

Feb 17, 2022
Safer Medical Devices: In vitro assays as part of your biological evaluation
By Dr Rose-Marie Jenvert

Jan 20, 2022
Why choose GARD for skin sensitization testing?
By Dr Andy Forreryd

Nov 18, 2021
Safety Testing of Cosmetic Products
Joint webinar

Nov 11, 2021
Recap on SenzaGen’s Eurotox Industry Symposium: Filling data gaps in skin sensitization testing
By Dr Andy Forreryd, Dr Marco Corvaro, Dr Peter Mohlin

Sep 16, 2021
New opportunity: How is GARD used for skin sensitization testing?
By Dr Rose-Marie Jenvert

May 27, 2021
Skin Sensitizing Potency Assessment: Filling in data gaps
By Dr Andy Forreryd and Dr Tim Lindberg

April 28, 2021
In vitro technology replacing animal models for skin sensitization testing
By Anna Chérouvrier Hansson and Ulrika T Mattson

April 14, 2021
SenzaGen’s 2021 SOT poster presentations
By Dr Henrik Johansson and Dr Ron Brown

  • Poster #1. Quantitative Sensitizing Potency Assessment Using GARD™skin Dose-Response | Download a copy
  • Poster #2. Applicability Domain of the GARD™skin Medical Device Test for In Vitro Skin Sensitization Testing of Medical Devices (MDCPSS Best Overall Abstract) | Download a copy

March 11, 2021
Joint webinar in French: Cosmetic Safety 3.0 – Webinaire France (new session)
By PKDerm, GenEvolutioN, CEHTRA and SenzaGen

February 25, 2021
How is GARD™ used for sensitization testing?
By Rose-Marie Jenvert, PhD, SenzaGen

January 27, 2021
Why choose GARD™ for sensitization testing?
By Andy Forreryd, PhD, SenzaGen

October 21, 2020
Safer Medical Devices – in vitro skin sensitization testing with human relevance and high accuracy
By Rose-Marie Jenvert, PhD, and Joshua Schmidt, PhD, SenzaGen

October 6, 2020
Joint webinar in French: Cosmetic Safety 3.0 – Webinaire France
By PKDerm, GenEvolutioN, SenzaGen

Cosmetic Safety 3.0 - Webinaire France Recording

September 15, 2020
Joint webinar: Your Guide to GARD®
– New generation skin sensitisation testing technologies explained

By Carol Treasure, PhD, XCellR8 and Andy Forreryd, PhD, SenzaGen AB

June 17, 2020
Web-based launch: The NEW GARDskin Dose-Response
By Andy Forreryd, PhD, SenzaGen AB

View webinar

May 26, 2020
Genomics and Machine Learning for In Vitro Sensitization Testing of Challenging Chemicals
By Henrik Johansson, PhD, and Andy Forreryd, PhD, SenzaGen AB

March 26, 2020
Web-based conference on “Difficult-to-test” substances and regulatory testing
By Andy Forreryd, SenzaGen AB and guest speakers from Eurofins, Lubrizol and MB Research Labs

Session recordings
Dr Andy Forreryd, SenzaGen
Helge Gehrke, Eurofins BioPharma Product Testing
Dr. George DeGeorge, MB Research Labs

February, 2020

In vitro sensitization testing based on genomics and machine learning
By Angelica Johansson, SenzaGen AB

October, 2019

In vitro sensitization testing of Medical Devices – GARDskin Medical Device 
By Rose-Marie Jenvert, PhD, SenzaGen

September 2019

How are the in vitro GARD™ assays used in real life? – Cases and applications for testing of skin and respiratory sensitizers
By Andy Forreryd, PhD, SenzaGen

April 2019

Genomics and Machine Learning – All you need to know about the GARD™ technology for in vitro sensitization testing
By Andy Forreryd, PhD, SenzaGen